Description
EIDD-1931, β-d-N4-hydroxycytidine is a ribonucleoside analog that has broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and related zoonotic group 2b or 2c bat-CoVs.
EIDD-1931
Product ID E325127
Cas No. 3258-02-4
Purity ≥99%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Cas No. | 3258-02-4 |
|---|---|
| Purity | ≥99% |
| Formula | C9H13N3O6 |
| Formula Wt. | 259.22 |
| Chemical Name | β-d-N4-hydroxycytidine |
| IUPAC Name | N-Hydroxycytidine |
| Synonym | EIDD1931; β-d-N4-hydroxycytidine; Cytidine, N-hydroxy-; N4-Hydroxycytidine; N-Hydroxycytidine; Uridine, 4-oxime |
| Appearance | White to off white crystalline powder |
Shipping and Storage
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet |
References
T. P. Sheahan, A. C. Sims, S. Zhou et. al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci transl Med. 12(541), 2020:eabb5883, PMID: 32253226 PMCID: PMC7164393 DOI: 10.1126/scitranslmed.abb5883